Navigation Links
'Cookbook recipes' would cure disease with nontoxic DNA delivery systems

Scientists studying the structure and interaction of negatively charged lipids and DNA molecules have created a "cookbook" for a class of nontoxic DNA delivery systems that will assist doctors and clinicians in the safe and effective delivery of genetic medicine.

As reported in the Aug. 9 issue of the Proceedings of the National Academy of Sciences, researchers have now performed a careful, comprehensive study to see how negatively charged lipids stick to negatively charged DNA and self-organize into structures.

"Many research groups have made concoctions with ingredients in different proportions and then assessed their effectiveness in gene delivery, but this is hard and requires a lot of intuition," said Gerard Wong, a professor of materials science and engineering, physics, and bioengineering at the University of Illinois at Urbana-Champaign, and corresponding author of the paper.

"By understanding some of the physics, we now have recipes for assembling delivery systems with different structures, which can have intrinsically different, controllable DNA delivery efficiencies," Wong said. "We found that the same family of structures are generated for many different ions."

Gene therapy is one of the most promising strategies for developing cures for many hereditary and acquired diseases. Protocols have been approved for treating cancer, cystic fibrosis and neuromuscular disorders, for example, but delivering DNA to the proper location and getting the right amount of DNA expression without killing innocent cells has become the Achilles' heel in DNA delivery.

Positively charged (cationic) synthetic molecules will readily bond to negatively charged DNA molecules and have been used for DNA delivery, but these cationic molecules are often toxic to cells, Wong said. An alternative is to use naturally occurring negatively charged (anionic) lipids that won't harm cells.

"The problem then becomes: 'How do you stick a negatively charged lipid to a negatively charged DNA molecule?'" said Wong, who also is a researcher at the Beckman Institute for Advanced Science and Technology. "One idea is to glue the lipids and DNA together with positively charged ions like calcium."

Using synchrotron small angle X-ray scattering and confocal microscopy, Wong and his colleagues -- former Illinois graduate student Hongjun Liang (now a postdoctoral researcher at the University of California at Santa Barbara) and theoretician Daniel Harries at the National Institutes of Health -- investigated how different ion-mediated interactions were expressed in self-assembled anionic lipid-DNA structures.

At low membrane charge densities, for example, anionic lipids and DNA molecules self-assemble into structures with alternating layers of DNA and anionic membranes bound together by cations, Wong said. At high membrane charge densities, there is a surprise: The DNA is expelled, leaving a stack of anionic membranes glued together by cations -- a feature that could prove useful in other controlled drug delivery applications.

The researchers also produced inverted hexagonal structures with encapsulated DNA. "First, the strands of DNA are coated with positively charged ions," Wong said. "The strands are then wrapped with negatively charged lipids and resemble tubes, which are then grouped into hexagonal arrangements."

Utilizing naturally occurring anionic lipids instead of cationic lipids "creates a whole hierarchy of interactions and a much richer range of structures," Wong said, "which really opens up new possibilities."


Source:University of Illinois at Urbana-Champaign

Related biology news :

1. $5.1 billion would save 6 million children
2. President Bushs cut to AIDS prevention in Africa would be devastating
3. Ethical guidelines suggested for research that would put human stem cells in primates
4. Proposal would allow wild animals to roam North America
5. New discovery: If it werent for this enzyme, decomposing pesticide would take millennia
6. Some people would give life or limb not to be fat
7. Designer babies - what would you do for a healthy baby?
8. Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?
9. Neuronal traffic jam marks early Alzheimers disease
10. Scientists detect probable genetic cause of some Parkinsons disease cases
11. Ecological destruction fuels emerging diseases
Post Your Comments:

(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the ... the Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s ... how hardware projects are designed, built and brought to market. , The Design ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: